Ajax-Loading

Astellas Pharma Inc. - Short Term Debt

Astellas Pharma Inc.'s Fiscal Year is From April To March - All Figures are in JPY, Billions.

The item "Short-Term-Debt" stands at 331.41 Billion Japanese Yens as of 06/30/2025.

As of the end of Astellas Pharma Inc.'s first quarter, the item "Short Term Debt" stands at 331.41 Billion JPY. This represents an increase of 24.34 percent compared to it's value at the end of it's fourth quarter of the company's last fiscal year.


Regarding the One-Year-Change of the series, the current value constitutes a decrease of -39.70 percent compared to the value the year prior.
The 1 year change in percent is -39.70.

The Serie's long term average value is 227.21 Billion Japanese Yens. It's latest available value, on 06/30/2025, is 45.86 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 03/31/2017, to it's latest available value, on 06/30/2025, is +15,871.76%.
The Serie's change in percent from it's maximum value, on 06/30/2024, to it's latest available value, on 06/30/2025, is -39.70%.

Short Term Debt for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Short Term Debt905,699,262,464.00
LogoJohnson & Johnson - Short Term Debt486,508,953,600.00
LogoAbbVie Inc - Short Term Debt399,570,305,024.00
LogoRoche Holding AG - Short Term Debt317,433,206,677.55
LogoAstraZeneca PLC - Short Term Debt280,205,508,085.11